Examples of using Lucentis in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
Withholding Lucentis.
How has Lucentis been studied?
What is the risk associated with Lucentis?
Before stopping Lucentis treatment.
What Lucentis looks like and contents of the pack.
How to prepare for Lucentis treatment.
All Lucentis injections will be administered by your doctor.
Avastin is the molecule from which Lucentis is derived.
After Lucentis treatment you may experience some temporary vision blurring.
The full EPAR for Lucentis can be found here.
Breast-feeding is not recommended during the use of Lucentis.
Lucentis is not recommended during breast-feeding because it is not known whether Lucentis.
These medical devices are not included within the Lucentis pack.
By binding to VEGF-A, Lucentis can block its actions
Ask your doctor or pharmacist for advice before Lucentis treatment.
The safety and efficacy of Lucentis therapy administered to both eyes concurrently have
Proper aseptic injection techniques must always be used when administering Lucentis.
There is some experience of Lucentis administered concomitantly with laser photocoagulation see section 5.1.
please discuss this with your doctor before Lucentis treatment.
What Lucentis looks like and contents of the pack Lucentis is a solution for injection in a vial 0.23 ml.
arterial thromboembolic events was observed in the Lucentis clinical trials and there were no major differences between the treatment groups.
Lucentis is not recommended during breast-feeding because it is not known whether Lucentis passes into human milk.
Treatment consists of Anti-VEGF drugs like Lucentis or intravitreal steroid implant(Ozurdex) and Pan-Retinal Laser Photocoagulation usually.
The Lucentis treatment procedure may induce temporary visual disturbances,
The Committee decided that Lucentis' s benefits are greater than its risks for the treatment
Of Lucentis- treated patients experienced a clinically significant improvement in vision, defined
If you are considering stopping Lucentis treatment, please go to your next appointment and discuss this with your doctor.
When initiating Lucentis therapy, caution should be used in patients with
Patients received Lucentis 0.3 mg or 0.5 mg intravitreal injections
Children and adolescents Lucentis is not recommended for use in children